Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Spiekermann

Showing results (31-40 of 202) with videos related to

Pageof 21
Sort By:
PLOS Digital Health|March 15, 2023
Explainable AI identifies diagnostic cells of genetic AML subtypesMatthias Hehr, Ario Sadafi, Christian Matek, et al.
Scientific Reports|December 1, 2015
Microenvironmental hypoxia regulates FLT3 expression and biology in AMLSilvia Sironi, Michaela Wagner, Alexander Kuett, et al.
Innere Medizin (Heidelberg, Germany)|October 1, 2024
[Recurrent hemolysis and iron overload of unclear origin]Laura Distelmaier, Christian Gebhard, Antje Holzäpfel, et al.
Scientific Data|November 11, 2025
A large expert-annotated single-cell peripheral blood dataset for hematological disease diagnosticsSayedali Shetab Boushehri, Salome Kazeminia, Armin Gruber, et al.
Blood|January 1, 2005
FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L)Ksenia Bagrintseva, Stefanie Geisenhof, Ruth Kern, et al.
World Neurosurgery|April 19, 2019
Perioperative Management of a Patient with Severe Factor V Deficiency Presenting with Chronic Subdural Hematoma: A Clinical ReportAgnes S Meidert, Johannes Kinzinger, Patrick Möhnle, et al.
The American Journal of the Medical Sciences|December 14, 2011
Chronic granulomatous disease in an adult recognized by an invasive aspergillosisInes Kaufmann, Josef Briegel, Verena van der Heide, et al.
British Journal of Haematology|August 24, 2017
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200Thomas Köhnke, Veronika K Wittmann, Veit L Bücklein, et al.
Blood|November 8, 2003
Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoietic cellsKsenia Bagrintseva, Ruth Schwab, Tobias M Kohl, et al.
British Journal of Haematology|December 6, 2008
Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factorChristina Papadaki, Annika Dufour, Marlene Seibl, et al.
Pageof 21

Showing results (31-40 of 202) with videos related to

Sort By:
Pageof 21
PLOS Digital Health|March 15, 2023
Explainable AI identifies diagnostic cells of genetic AML subtypesMatthias Hehr, Ario Sadafi, Christian Matek, et al.
Scientific Reports|December 1, 2015
Microenvironmental hypoxia regulates FLT3 expression and biology in AMLSilvia Sironi, Michaela Wagner, Alexander Kuett, et al.
Innere Medizin (Heidelberg, Germany)|October 1, 2024
[Recurrent hemolysis and iron overload of unclear origin]Laura Distelmaier, Christian Gebhard, Antje Holzäpfel, et al.
Scientific Data|November 11, 2025
A large expert-annotated single-cell peripheral blood dataset for hematological disease diagnosticsSayedali Shetab Boushehri, Salome Kazeminia, Armin Gruber, et al.
Blood|January 1, 2005
FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L)Ksenia Bagrintseva, Stefanie Geisenhof, Ruth Kern, et al.
World Neurosurgery|April 19, 2019
Perioperative Management of a Patient with Severe Factor V Deficiency Presenting with Chronic Subdural Hematoma: A Clinical ReportAgnes S Meidert, Johannes Kinzinger, Patrick Möhnle, et al.
The American Journal of the Medical Sciences|December 14, 2011
Chronic granulomatous disease in an adult recognized by an invasive aspergillosisInes Kaufmann, Josef Briegel, Verena van der Heide, et al.
British Journal of Haematology|August 24, 2017
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200Thomas Köhnke, Veronika K Wittmann, Veit L Bücklein, et al.
Blood|November 8, 2003
Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoietic cellsKsenia Bagrintseva, Ruth Schwab, Tobias M Kohl, et al.
British Journal of Haematology|December 6, 2008
Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factorChristina Papadaki, Annika Dufour, Marlene Seibl, et al.
Pageof 21